Cover Image
市場調查報告書

心臟生物標記診斷市場分析

Analysis of the Cardiac Biomarker Diagnostics Market

出版商 Frost & Sullivan 商品編碼 341834
出版日期 內容資訊 英文 116 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
心臟生物標記診斷市場分析 Analysis of the Cardiac Biomarker Diagnostics Market
出版日期: 2015年09月30日 內容資訊: 英文 116 Pages
簡介

心臟生物標記診斷在美國仍是利基,但未來有潛力的診斷技術。由於當局的方針是推廣個別化醫療、診斷,大企業投下巨額的資金在新生物標記的研究·發現上,以求與其他公司之差別化。除了心臟病潛在病人數一直在增加之外,各種可在臨床現場以照護現場 (POC) 方式利用,更是市場成長的要素。在「以患者為中心的醫療」為目的的動向擴大中,各家企業都在開發可在更多元現場使用的診斷藥,以建立其在市場上的優勢。

当レポートでは、心臓バイオマーカー診断の市場について分析し、技術上の特徴や基本的な市場構造、主な市場促進・阻害要因、全体的な市場動向の見通し、分野別の詳細動向、競争環境、他の診断技術との融合・連動の可能性、将来的な市場機会などについて調査・推計しております。

本報告提供心臟生物標記診斷的市場相關分析,提供您技術上的特徵和基本的市場結構,主要市場促進·阻礙因素,整體市場趨勢預測,各領域詳細趨勢,競爭環境,與其他診斷技術的融合·連鎖之可能性,未來的市場機會等調查評估。

第1章 摘要整理

第2章 市場概要

  • 心臟診斷藥產業概要
  • 心臟生物標記診斷概要
  • 市場背景
  • 市場背景:盛行率
  • 心臟診斷概要
  • 市場概要:檢驗次序
  • 左右診斷利用可能性的要素
  • 今後醫療趨勢的考察

第3章 競爭策略

  • 新的市場策略
  • 大企業的解決方案
  • 主要的產業聯盟:心臟生物標記與體外診斷 (IVD)
  • 心肌梗塞 (MI) 的新生物標記和臨床上的優點

第4章 新的生物標記

  • LDT (自製·未核准診斷藥) :心臟診斷的作用
  • 其他新生物標記

第5章 推動及阻礙市場要素:心臟生物標記診斷整體市場

  • 推動市場要素
  • 阻礙市場要素

第6章 市場預測與趨勢:心臟生物標記診斷整體市場

  • 市場測量
  • 市場預測的前提條件與定義
  • 市場收益額的預測
  • 各部門的收益額佔有率預測
  • 各部門的生命週期分析

第7章 競爭環境

  • 市場佔有率
  • 市場佔有率分析
  • 整體市場佔有率分析
  • 大企業

第8章 就地檢驗 (POCT) 部門分析

  • 市場測量
  • 市場收益額預測
  • POCT部門的佔有率
  • 各部門市場佔有率分析
  • 競爭產品比較表
  • 美國市場的主要的POCT設備
  • 競爭產品分析

第9章 實驗室產品部門分析

  • 市場測量
  • 市場收益額預測
  • 市場收益額預測:疾病類別
  • 市場成長率:心臟不同疾病
  • 產品系列
  • 價格趨勢與其預測
  • 各部門的市場佔有率
  • 競爭產品比較表

第10章 心臟診斷藥產業概要:整體情況

  • 心臟診斷藥產業概況
  • 產業聯盟的趨勢:醫療設備·診斷藥

第11章 心臟影像診斷

  • 產業概要
  • 產業概要:各用途
  • 新的市場機會
  • 影像診斷技術:各種患者診斷的作用

第12章 心臟診斷用的心電圖 (ECG)

  • 產業概要
  • 心臟監測功能:各應用領域
  • 新的市場機會
  • ECG技術:各種患者的診斷作用

第13章 市場機會

  • 市場機會:搭配診斷
  • 數位健康和診斷技術的一體化模式:心臟診斷的情況
  • 市場機會:影像診斷和體外診斷 (IVD) 的融合
  • 市場機會:值得注意的主要企業

第14章 結論

第15章 附錄

圖表一覽

目錄
Product Code: NF62-01-00-00-00

Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment

The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates that are driving this market, the increasing use of point-of-care testing devices at ambulatory and at clinical settings spurs this market in the region. The push towards a more patient centric and wholesome care places imaging companies that can provide a more comprehensive diagnostic product are at an advantage in this market.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Competitive Landscape
  • 4. Scope and Segmentation
  • 5. Key Questions This Study Will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Key Companies to Watch
  • 9. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

  • 1. Cardiac Diagnostics Industry Overview
  • 2. Cardiac Biomarkers Diagnostics Overview
  • 3. Market Background
  • 4. Market Background-Prevalence Rate
  • 5. Cardiac Diagnostics Overview
  • 6. Market Overview-Testing Procedure
  • 7. Factors Influencing Adoptability of Tests
  • 8. Defining Healthcare Trends in the Future

3. COMPETITIVE PLAYBOOK

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)
  • 3. Solutions Provided by Top Companies
  • 4. Important Partnerships-Cardiac Biomarker IVD Diagnostics
  • 5. Emerging Biomarkers for MI and Clinical Strength

4. EMERGING BIOMARKERS

  • 1. LDTs-Role in Cardiac Diagnostics
  • 2. Other Emerging Biomarkers

5. DRIVER AND RESTRAINTS-TOTAL CARDIAC BIOMARKER DIAGNOSTICS MARKET

  • 1. Market Drivers
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Drivers Explained (continued)
  • 5. Market Restraints
  • 6. Restraints Explained
  • 7. Restraints Explained (continued)

6. FORECASTS AND TRENDS-TOTAL CARDIAC BIOMARKER DIAGNOSTICS MARKET

  • 1. Measurements
  • 2. Forecast Assumptions and Definitions
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Percent Revenue Breakdown by Segments
  • 6. Segment Lifecycle Analysis

7. COMPETITIVE ENVIRONMENT

  • 1. Market Share
  • 2. Market Share Analysis
  • 3. Overall Market Share Analysis
  • 4. Top Competitors
  • 5. Top Competitors (continued)
  • 6. Top Competitors (continued)
  • 7. Top Competitors (continued)
  • 8. Top Competitors (continued)

8. POCT SEGMENT ANALYSIS

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. POCT-Segment Share
  • 5. Segment Share Analysis
  • 6. Competitive Value Matrix
  • 7. Top POCT Devices in the US Market
  • 8. Competitive Product Analysis
  • 9. Competitive Product Analysis (continued)
  • 10. Competitive Product Analysis (continued)
  • 11. Competitive Product Analysis (continued)
  • 12. Competitive Product Analysis (continued)

9. LAB-BASED SEGMENT ANALYSIS

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Disease Type
  • 4. Growth Rate by Cardiac Disease
  • 5. Revenue Forecast Discussion
  • 6. Revenue Forecast Discussion (continued)
  • 7. Product Portfolio
  • 8. Product Portfolio (continued)
  • 9. Pricing Trends and Forecast
  • 10. Segment Share
  • 11. Segment Share Analysis
  • 12. Segment Share Analysis (continued)
  • 13. Competitive Value Matrix

10. THE FULL PICTURE-CARDIAC DIAGNOSTICS INDUSTRY OVERVIEW

  • 1. Cardiac Diagnostics Industry Overview
  • 2. Partnership Trends-Medical Device Diagnostics

11. CARDIAC IMAGING DIAGNOSTICS

  • 1. Industry Overview
  • 2. Industry Overview by Application
  • 3. New Market Opportunities
  • 4. Imaging Technology-Role in Patient Continuum

12. ECG IN CARDIAC DIAGNOSTICS

  • 1. Industry Overview
  • 2. Cardiac Monitoring by Application
  • 3. New Market Opportunities
  • 4. ECG Technology-Role in Patient Continuum

13. OPPORTUNITIES

  • 1. Opportunities-Companion Diagnostics
  • 2. Opportunities-Companion Diagnostics (continued)
  • 3. Opportunities-Companion Diagnostics (continued)
  • 4. Opportunities-Companion Diagnostics (continued)
  • 5. Digital Health and Diagnostics Inter Convergence Model-Cardiac Diagnostics
  • 6. Opportunity-Convergence of Imaging and IVD
  • 7. Opportunities-Key Companies to Watch

14. THE LAST WORD

  • 1. The Last Word-3 Big Predictions
  • 2. The Last Word-3 Big Predictions Discussion
  • 3. The Last Word-3 Big Predictions Discussion (continued)
  • 4. Legal Disclaimer

15. APPENDIX

  • 1. List of Others
  • 2. Methodology
  • 3. Learn More-Next Steps
  • 4. List of Exhibits
  • 5. List of Exhibits (continued)
  • 6. List of Exhibits (continued)
  • 7. List of Exhibits (continued)

List of Exhibits

  • Total Cardiac Biomarker Diagnostics Market: Competitive Landscape, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Industry Overview, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Market Overview, US, 2014
  • Cardiac Biomarker Diagnostics Prevalence Rate, US, 2009-2020
  • Total Cardiac Biomarker Diagnostics Market: Market Segmentation, US, 2014
  • Total Cardiac Biomarker Diagnostics Adoptability of Biomarker Tests, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Market Outlook, US, 2014 and 2024
  • Total Cardiac Biomarker Diagnostics Market: Game-changing Strategies, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Company Offerings, US, 2014
  • Total Cardiac Diagnostic Market: Notable Deals and Trends, US, 2011-2014
  • Net Improvement in Predicting of 30-day Mortality, Emerging Biomarkers, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: LDTs vs FDA-approved Tests, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Emerging Biomarkers, US,2014
  • Total Cardiac Biomarker Diagnostics Market: Key Market Drivers, US, 2015-2020
  • Total Cardiac Biomarker Diagnostics Market: Key Market Restraints, US, 2015-2020
  • Total Cardiac Biomarker Diagnostics Market: Market Engineering Measurements, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Revenue Forecast, US, 2011-2021
  • Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown by Segment, US, 2021
  • Total Cardiac Biomarker Diagnostics Market: Segment Lifecycle Analysis, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: Percent Revenue Breakdown, US, 2014
  • Total Cardiac Biomarkers Diagnostics Market: Company Market Share Analysis of Top 4 Participants, US, 2014
  • Total Cardiac Biomarker Diagnostics Market: SWOT Analysis, US, 2014
  • POCT Segment: Market Engineering Measurements, US, 2014
  • POCT Segment: Revenue Forecast, US, 2011-2021
  • POCT Segment: Percent Revenue Breakdown, US, 2014
  • POCT Segment: Company Segment Share Analysis by Top 4 Participants, US, 2014
  • POCT Segment: Competitive Analysis, US, 2014
  • POCT Segment: Product Analysis, US, 2014
  • POCT Segment: Top 10 products, US, 2014
  • Lab-based Tests Segment: Market Engineering Measurements, US, 2014
  • Lab-based Tests Segment: Revenue Forecast, US, 2011-2021
  • Lab-based Tests Segment: Revenue Forecast by Disease Type, US, 2011-2021
  • Lab-based Tests Segment: Growth Rate by Cardiac Disease, US, 2011-2021
  • Lab-based Tests Segment: Product Analysis, US, 2014
  • Lab-based Tests Segment: Average Price, US, 2009-2021
  • Lab-based Tests Segment: Percent Revenue Breakdown, US, 2014
  • Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
  • Lab-based Tests Segment: Company Segment Share Analysis of Top 4 Participants, US, 2014
  • Lab-based Tests Segment: Competitive Analysis, US, 2014
  • Total Cardiac Diagnostics Industry: Industry Overview, US, 2014
  • Total Cardiac Diagnostic Industry: Notable Deals and Trends, US, 2011-2014
  • Total Cardiac Diagnostics Industry: Industry Overview, US, 2014
  • Total Cardiac Diagnostics Industry: Overview by Application, US, 2014
  • Total Cardiac Diagnostics Industry: Game-changing Strategies, US, 2014
  • Total Cardiac Diagnostics Industry: Patient Continuum, US, 2014
  • Total Cardiac Diagnostics Industry: ECG, US, 2014
  • Total Cardiac Monitoring Market: Market Segmentation, US, 2014
  • Total Cardiac Monitoring Market: Game-changing Strategies, US, 2014
  • Total Cardiac Diagnostics Industry: Patient Continuum, US, 2014
  • Total Cardiac Diagnostic Industry: Companies Pursuing CDx Opportunities, US, 2013-2015
  • Total Cardiac Diagnostic Industry: Pipeline Drugs for Each Cardiovascular Disease, US, 2013-2015
Back to Top